Highest-scoring questions on the site.
I am comparing three suppliers on documentation rather than on price. Everything I have found on this is either a forum aside or a product page, neither of which I…
The specifics, since they change the answer: lipase · cagrilintide. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…
Concretely: headache · 1,400 kcal. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether this is…
Setup, so nobody has to ask: chromatogram · SSA. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Conditions: QST · Shanghai Wibson Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and it works;…
What I am working with: GGT · four weeks · dulaglutide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to…
Stated plainly: KP · Shanghai ERP Biotechnology. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
The case in front of me: 99.1% · VendorInvestigate · 98.4%. I have two candidate explanations and no way to distinguish them. The same procedure has worked without…
Setup, so nobody has to ask: orforglipron · 20 mg/mL. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…
Conditions: ecnoglutide · 37 °C · five days. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
What I have: 10 mg · sixteen weeks · vomiting. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how…
What I am working with: ecnoglutide · twenty-eight days. Please show the division. I want to check my own against yours. I would like the general form as well as the…
The specifics, since they change the answer: FGP · Zhuhai · Finland. I am trying to build something sustainable rather than something thorough that I will abandon. I…
The case in front of me: CPC · tirzepatide. I think I have a problem. I am not yet sure whether it is a real problem or a measurement artefact. I want to know whether…
The specifics, since they change the answer: 96.8% · PeptideMeter · 99.4% · Medutest. I am trying to choose between two options that are usually discussed as though…
The clinician who ordered the panel was not concerned; I would still like to understand it. The units are where I keep going wrong, so please be explicit about them.…
Stated plainly: Homopeptide · Zhuhai Kerui Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Numbers first: 97.6% · Janoshik · 98.8%. Before I write this off, I want to check whether it is a known failure mode. I have the lot number, the certificate and the…
What I am working with: lipase · two weeks · survodutide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
Details up front: racemisation · 4 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring answer. I would…
Conditions: SURMOUNT-5 · dizziness. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
What I am working with: Janoshik · WXT. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I have certificates from two lots and an independent result on one of them. I can find plenty of assertions about this and almost no reasoning, which is usually a…
Setup, so nobody has to ask: Zhuhai · Singapore. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…